eFFECTOR(EFTR) - 2023 Q4 - Annual Report
eFFECTOReFFECTOR(US:EFTR)2024-03-26 12:57

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39866 eFFECTOR Therapeutics, Inc. (Exact name of Registrant as specified in its Charter) Delaware 85-3306396 (State or other jurisdiction of incorporation or organization) 142 North Cedros Avenue, Suite B Solana Beach, CA 92075 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION ...